Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non–Small-Cell Lung Cancer

Published:2013-02 Issue:2 Volume:8 Page:192-201
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Robinson Cliff G.,DeWees Todd A.,El Naqa Issam M.,Creach Kimberly M.,Olsen Jeffrey R.,Crabtree Traves D.,Meyers Bryan F.,Puri Varun,Bell Jennifer M.,Parikh Parag J.,Bradley Jeffrey D.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Reply to difference in outcome in the transection of the pulmonary artery and vein;Flores;J Thorac Cardiovasc Surg,2011

2. The new lung cancer staging system;Detterbeck;Chest,2009

3. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis;El-Sherif;Ann Thorac Surg,2006

4. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group;Ginsberg;Ann Thorac Surg,1995

5. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer;Birdas;Ann Thorac Surg,2006

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma;Radiotherapy and Oncology;2024-06

2. Research Progress of Radiotherapy Combined with Immunotherapy in Non-Small Cell Lung Cancer;Journal of Clinical Personalized Medicine;2024

3. Research Progress on Interventional Time and Safety of RT Combined with ICIs for NSCLCL;Advances in Clinical Medicine;2024

4. Influence de l’immunothérapie sur le choix du traitement des cancers bronchiques non à petites cellules de stade I : point de vue de l’oncologue radiothérapeute;Cancer/Radiothérapie;2023-09

5. Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study;Radiation Oncology;2023-08-24